Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions
- Corporate strategy - The publisher's summarization of the company’s business strategy
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats
- Company history - Progression of key events associated with the company
- Major products and services - A list of major products, services and brands of the company
- Key competitors - A list of key competitors to the company
- Key employees - A list of the key executives of the company
- Executive biographies - A brief summary of the executives’ employment history
- Key operational heads - A list of personnel heading key departments/functions
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details
Highlights
Urigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company focuses on the development of products for symptoms associated with urological ailments and painful bladder syndrome (PBS). Its pipeline products include URG101 and URG501, intended for the treatment of interstitial cystitis and bladder pain syndrome. It also focuses on the development of URG 801, which is in the preclinical stage for the treatment of Hunner’s lesions of severe interstitial cystitis and bladder pain syndrome. Urigen is headquartered in Bound Brook, New Jersey, the US.Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy
- Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Janssen Pharmaceuticals Inc
- rEVO Biologics Inc
- Mission Pharmacal Co
- Plethora Solutions Holdings Plc
- Halozyme Therapeutics Inc